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Abstract The chemical reactivity of as-anodized porous
silicon is shown to have an adverse effect on a model drug
(Lansoprazole) loaded into the pores. The silicon hydride
surfaces can cause unwanted reactions with actives dur-
ing storage or use. Techniques such as thermal oxidation
or surface derivatization can lower the reactivity some-
what, by replacing the reactive silicon-hydride species with
a more benign oxide or functional group. However, by
using a trio of analytical techniques (fluorometric dye assay,
HPLC assay, and chemography) we show that residual
hydride is still likely to be present and only after com-
bining thermal oxidation with surface derivatization can
the residual reactivity be reduced to those values typically
observed with sol-gel (porous) silica. Potential sources of
residual reactivity are discussed, with reference to data
obtained by trace metal analysis, residual solvents, and pH
measurements.
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1 Introduction
Porous silicon has been under pre-clinical evaluation for
drug delivery for a number of years [1–6]. Its medical
biodegradability and biocompatibility [7–9], widely tune-
able pore sizes via electrochemical etching [10, 11], flexible
surface chemistry [12, 13] and high payloads of nanos-
tructured drugs [14] are its key attributes in this regard.
However, biodegradable materials are generally, almost by
definition, more chemically reactive than “bio-inert” ones.
Biodegradable polymers, for example, liberate acidic by-
products that are well known to introduce local pH changes
that can damage the tertiary structure of large biomolecules
like proteins [15, 16]. Biodegradable metal degradation
products, like hydrogen gas from magnesium, may cause
adverse reactions in vivo [17] and may lead to body fluid
alkalization locally [18].
Biodegradable semiconducting silicon degrades into
orthosilicic acid in vivo, which is naturally present in the
human body [19], but can also release trace levels of silane
[20] and can contain residual silicon-hydride bonds after
thermal passivation (oxidation) treatments (21). If insuffi-
cient post-etch rinsing and drying is carried out the material
can also contain sufficient HF-based electrolyte, solvent
residues and etch by-products to cause cytotoxicity and
reactivity [22]. Pharmacopeia requirements for drug formu-
lations include very low levels of “Active Pharmaceutical
Ingredient” (API) modification during long term storage
(e.g. <5% over 6 months). This necessitates modifying the
vehicle or carrier if it interacts with API chemistry. In the
case of mesoporous silicon, optimizing the pore wall chem-
istry to minimize any chemical reactions with the entrapped
drug molecules is a prerequisite before loading it with active
molecules.
Silicon
Porous silicon is commonly manufactured by the etching
of crystalline silicon in aqueous and non-aqueous elec-
trolytes containing hydrofluoric acid [23]. The surface of
freshly prepared porous silicon is covered with a layer of
Si-H bonds with minor quantities of Si-F and Si-O species
also present. The reactivity of as-etched porous silicon is
dominated by the chemistry of Si-Si and Si-H bonds [12]
particularly when trying to load biomolecules or actives in
pores for drug delivery. As etched (as-anodized) porous sil-
icon contains a high concentration of silicon hydride bonds
at its surface; which act as a reducing agent. Therefore to
make the material non-reactive with APIs, the Si-H bonds
are oxidized to yield a passivated product, which is less
reactive due to lower amounts of hydrides [20, 21]. Deriva-
tization of Si-H bonds with aminosilane compounds like
APTES or APDMES has also been employed to make the
pore wall surface more stable and more compatible with
biomolecules such as oligonucleotides [24].
In the present study, reactions of residual hydride of
thermally annealed, oxide-passivated, derivatized or both
oxidized and derivatized porous silicon samples were stud-
ied using three distinct assays. The first of these is a
chemical method based on hydride-mediated degradation
of the Lansoprazole drug, a substituted 2-(2-pyridylmethyl)
sulfinyl benzimidazole molecule, used as a PPI (proton
pump inhibitor) in the inhibition of gastric acid secretion.
Lansoprazole shows high sensitivity to proton attack at the
sulfoxide group under weak acidic conditions [25]. Silicon
hydride bonds at the pore wall surface act as a reduc-
ing agent when in contact with the Lansoprazole molecule.
This reducing effect on Lansoprazole is proportional to
the hydride content of the porous silicon material and the
drug will degrade in the reaction mixture accordingly. The
percentage of degraded Lansoprazole can be used as a
direct measurement of the chemical reactivity of the porous
silicon.
A second method also uses a hydride-mediated oxida-
tion reduction of phenoxazin-3-one dyes Resazurin and
Resorufin [26]. In this assay, hydride from porous sili-
con reduces the weakly fluorescent dye Resazurin to the
highly fluorescent molecule Resorufin at pH 7.6 in phos-
phate buffer [27]. At the emission peak of Resorufin (587
nm), fluorescence from Resazurin is negligible and is used
as a blank in the assay procedure.
The third approach for reactivity assessment is chemo-
graphic analysis of the samples. Porous silicon releases
low levels of gaseous silanes in humid air which create
images on photographic plates through reduction of the sil-
ver halide in a photographic emulsion [28]. The low levels
of monosilane emission are thought to be primarily due
to hydrolysis of Si-H3 bonds, so relatively high concentra-
tions of hydrides on the surface will cause the chemographic
effects to be more pronounced for as-etched material
than oxide-passivated or derivatized porous silicon surfaces
[29].
We believe that these three methods complement each
other in analyzing the residual hydrides within porous sil-
icon post oxide-passivation or derivatization, so they were
simultaneously used following a variety of chemical pas-
sivation treatments on a specific porous silicon structure,
in order to quantitatively compare the resulting residual
reactivity.
2 Materials and Methods
2.1 Reagents
3-aminopropyltriethoxysilane (APTES), 3-aminopropyltri-
ethoxysilane (APDMES), 1-decene, Resazurin, Resorufin
and Lansaprazole were purchased from Sigma Aldrich. All
other solvents and buffers were purchased from Sigma and
were research-grade chemicals.
2.1.1 Manufacture of Porous Silicon Particles
Porous silicon microparticles were prepared from six inch
diameter p+ wafers (boron-doped, resistivity range 0.005-
0.02 .cm) via anodization in an HF-methanol based elec-
trolyte. Current density and time were chosen to yield
two forms of free-standing mesoporous silicon layers: (a)
average porosity of 86% and 227 μm thickness (sample
BS419) and (b) average porosity of 68% and 150 μm
thickness (sample BS445); after rinsing and drying, the
higher-porosity samples were ball-milled at 300 rpm in air
for 1min, then passed through a 53 μm stainless steel sieve
to obtain a powder with a defined particle size distribu-
tion (Table 1); samples BS419 were subsequently oxidized
at 700 ◦C for 16 hours in a Carbolite HTR 11/75 rotary
furnace and then hydrated in deionized water before dry-
ing under vacuum overnight. The lower-porosity samples
(BS445) were rotor-milled at 20,000 rpm to yield powder
with a size distribution and gas adsorption properties shown
in Table 1.
2.1.2 Characterization of Porous Silicon Particles
Porous silicon particle size was measured using the Mas-
tersizer 2000 laser diffraction system with a Hydro MU
dispersion unit. The material was wet to a paste with 5%
(w/w) Igepal CA (aq) before being dispersed in deion-
ized water for measurement. The raw scattering data was
deconvolved using Mie theory and an average particle size
distribution was generated from five measurements.
Gas adsorption analysis on the porous silicon powders
was conducted with nitrogen and a Micromeritics TriStar
Silicon
Table 1 Physicochemical
properties of oxidized porous
silicon microparticles prior to
derivatization treatments
Property Milled pSi (BS445) Milled & Oxidised pSi (BS419)
Particle size distribution d10 = 1.5 μm; d50 = 17.8 μm;
d90 = 44.2 μm
d10 = 3.9 μm; d50 = 15 μm; d90
= 43 μm
Surface area (m2/g) 287 217
Pore volume (ml/g) 0.994 0.969
Pore size (APD in nm) 13.7 16.6
pHa Not measured 4.1 +/- 0.2
Residual solventsa (ethanol/methanol) Not measured <1000 ppm
Heavy metal impurities (class 1)a Not measured None detected (XRF)
Heavy metal impurities (class 2)a Not measured Cu (17-22 ppm), Ni (11-12 ppm)
aData from other batches made under nominally similar conditions
3000 system. Computational analysis of the isotherms
yielded absolute values for surface area (based on the
Brunauer-Emmett-Teller/BET method), pore volume (based
on the Barrett-Joyner-Halenda/BJH method) and average
pore diameter (APD from BJH adsorption data).
Chemical purity with respect to trace heavy metals was
assessed in selected batches via X-ray fluorescence (XRF)
carried out using a Bruker S8 Tiger spectrometer with a
semi-quantitative software analysis suite. 1 g batches of
material were loaded into aluminum sample cups and held
in place with an ultrathin Mylar film.
Residual solvent levels (ethanol and methanol) in
selected batches were quantified with a PerkinElmer
Autosystem XL Gas Chromatography system with a BP-
624 capillary column following the pharmacopeia protocol
USP/NF 467.
pH was determined using the pharmacopeia protocol
USP/NF 791 wherein a suspension of 0.2 g +/- 0.01 g mate-
rial is sonicated for 1 minute in 5.0 ml of carbon-dioxide
free water. Measurements were conducted on a calibrated
Mettler Toledo MP225 pH meter at 25+/- 2 ◦C.
FTIR was conducted on a Nicolet Continu μm XL
Thermo Scientific, equipped with a microscope; measure-
ments were performed in reflection mode on an area of 100
× 100 μm2. The number of scans was set to 64. Spec-
tra were collected in the range of 4000–500 cm−1 with a
resolution of 2 cm−1.
Surface charge measurements of bare and functionalized
porous silicon nanoparticles were carried out by dynamic
light scattering (DLS) using a Zetasizer Nano ZS (Malvern
Instruments, Malvern, UK).
2.1.3 Hydrosilylation of Porous Silicon Particles
Porous silicon microparticles were placed in a Schlenk tube
containing a deoxygenated neat 1-decene (99% v/v) and
allowed to react at 110 ◦C for 18 h under a stream of argon
(Fig. 1, II, III).
Microparticles were extensively washed in tetrahydrofu-
ran and chloroform so as to remove excess of unreacted and
physisorbed reagent. Microparticles dispersion was cen-
trifuged at each wash for 30 min at 13,000 rpm and the
supernatant was discarded.
2.1.4 Silanization of Porous Silicon Particles
The functionalization procedure is based on silane
chemistry. PSi-NPs were treated with Piranha solution
(H2O2:H2SO4 1:4), in order to create OH groups, for 30
minutes at ambient temperature. After treatment with the
Piranha solution, samples were extensively washed in milli-
Q water to remove any adsorbed acid (Fig. 1, I). The
microparticle dispersion was centrifuged for 30 minutes at
13,000 rpm and the supernatant was discarded. The pellet
was silanized by immersion in 5% aminosilane solution;
APTES or APDMES in dry ethanol for 1 hour at room
temperature. After silanization, samples were extensively
washed in dry ethanol and then centrifuged for 30 min at
13,000 rpm and the supernatant discarded. The pellet was
incubated for 10 minutes at 100 ◦C (curing process).
2.1.5 Chemical Reactivity of Porous Silicon by RP-HPLC
Method
HPLC was performed using an Agilent 1200R series with a
C18 bonded stationary phase. The separation was achieved
with an ACE C18 (150 × 4.6 mm) column. Solvent A
consisted of water and solvent B consisted of acetonitrile:
water: triethylamine (80: 20: 0.005), the pH of solvent B was
adjusted to 7 with orthophosphoric acid (85% v/v). These
solutions were used to set up a gradient elution method. The
mobile phase is run through the column on a linear gradi-
ent of increasing organic modifier; flow rate was set at 0.8
mL/min and the eluent was monitored at 285 nm.
Lansoprazole is separated from its associated degrada-
tion products according to the RP-HPLC method described
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Fig. 1 Thermal and chemical passivation of porous silicon powders: (I) thermal oxidation and BS419 silanization process by APTES or
APDMES; (II) BS445 chemical passivation by hydrosilylation with 1-decene; (III) BS445 annealing and hydrosilylation by 1-decene
in the United States Pharmacopeia [30] for this molecule.
The Lansoprazole solution was accurately prepared at an
API concentration of 10 mg/mL in methanol. Each sample
required 100 μL of the Lansoprazole solution. Approx-
imately 20 mg (± 2 mg) of each silicon /silica sample
was weighed in duplicate into a 5 mL freeze drying vial.
Approximately 100 μL of the Lansoprazole/methanol solu-
tion was added to the samples and sealed with a butyl
stopper and aluminum overseal. The samples were placed in
a 25 ◦C water bath and incubated for 2 hours. As a control
sample, 100 μL of the Lansoprazole/methanol solution was
pipetted into a 5 mL freeze drying vial and incubated along-
side the other samples. As-anodized porous silicon was used
as a positive control which showed maximum degradation
of the drug compared with other samples.
After incubation, the overseal and the stopper were
removed, taking care as the vial may contain gas as a result
of any reactivity associated with the porous silicon. Each
sample and the Lansoprazole control was diluted with 4.9
mL methanol and gently mixed. The porous silicon was
allowed to settle, and then 1 mL of the supernatant was
removed and filtered into a HPLC vial using a Whatman 0.2
μm PVDF filter.
Each sample was assayed by RP- HPLC (25, 30) to deter-
mine the total percentage of degradation in the samples
in comparison to the control (Lansoprazole in methanol)
solution. The method was validated for specificity and
reproducibility.
2.1.6 Dye Reactivity by Fluorimetric Method
A PerkinElmer 1420 Victor3 Multilevel Counter was used
to quantify the highly fluorescent pink Resorufin dye which
is produced by reduction of blue Resazurin by hydride
surfaces of porous silicon. Fluorescence measurements uti-
lized a CW lamp filter of 531 nm (excitation) and emission
filter of 616 nm for quantification. (Alamar Blue assay, US
patent No5, 501,959).
About 15% solutions of Resazurin and Resorufin were
prepared in 50 mM phosphate buffer pH7.6. From the stock
solution of Resorufin various dilutions were made in phos-
phate buffer (pH7.6) to achieve a sufficient number of
solutions within the concentration range 0-2.0 μg/mL for
the generation of a standard calibration plot.
From the 15% solution of Resazurin, a 2.5 μg/mL work-
ing solution was prepared in the same phosphate buffer
(pH7.6). Duplicate samples of 20 ± 0.5 mg pSi were
weighed into amber Eppendorf tubes. About 1 mL of the
2.5 μg/mL working Resazurin dye solution was added to
each silica/silicon sample to give a suspension of 20 mg/mL.
After two hours of incubation at 25 ◦C, the Eppendorf tubes
were centrifuged at 14000 rpm for 2 minutes and 200 μL
of the supernatant liquid was transferred to a 96 well plate
in triplicate. The fluorescence values of each sample were
compared to that of the blue Resazurin dye solution, to that
of silica which has no hydride bonding and to that of 500 ◦C
oxidized pSi which has a significant number of hydrides but
still can be wetted with the buffer.
2.1.7 Chemographic Method:
Chemography utilized 25 μm thick Ilford L4 nuclear track-
ing emulsion plates with a custom built light-tight box
wherein there was 100% humidity at 25 ◦C.
Porous silicon powders (20 mg) which were as-etched,
oxide passivated or derivatized were weighed and then
placed in direct contact with the nuclear emulsion plate in
air of 100% relative humidity at 25 ◦C for times ranging
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from 10 minutes to 100 hours in complete darkness. The
position of the powders was recorded by photography prior
to plate exposure. After exposure, the plates were soaked in
Ilford developer for 2 minutes, soaked in Ilford stop solution
for 1 minute and fixed in Ilford fixer for 15 minutes. All of
these operations were conducted at 25 ◦C. Subsequent plate
washing in stream of water for 15 minutes was again carried
out at room temperature.
2.2 Results
2.2.1 Derivatization of pSi Particles
Porous silicon particles surface chemistry has been modi-
fied in three different ways, sketched in Fig. 1: the first route
is a three-step procedure which starts with a thermal oxida-
tion in wet atmosphere at 400 ◦C, followed by an activation
in Piranha solution and a silanization of powders that leads
to an amino-terminated surface; the second is a direct passi-
vation of the pSi surface in pure 1-decene which gives a Si-C
surface; the third is thermal annealing in inert atmosphere at
400 ◦C plus hydrosilylation, having the same result as route
(II).
The passivation treatments of pSi powders were anal-
ysed by FTIR spectroscopy. In Fig. 2 and Table 2 the
spectra changes of SiH and annealed SiH powders after
thermal hydrosylilation by 1-decene are reported: the com-
parison between FTIR spectra before and after treatments,
confirmed an almost complete conversion of pSi particle
surface chemistry. The evidence is the presence of charac-
teristic peaks of Si-C covalent bond: stretching modes of
C–Hx bonds at 2957-2853, 1465-1368 and 725-720 cm−1.
However, all FTIR spectra showed a weak characteristic
peak of backbone Si–H bonds at 2100 cm−1 and the peak of
Table 2 FTIR peak values of porous silicon powders (BS419) after
hydrosilylation process
Si–O–Si stretching mode at 1090-1100 cm−1 probably due
to spontaneous ageing of pSi powders during the handling.
FTIR spectra of SiH and SiO2 powders, in Fig. 3 and
Table 3, confirmed the success of silanization: both samples
showed the peaks at 1655 and 1550 cm−1, correspond-
ing to the bending mode of the free NH2 groups, the CHx
asymmetric/CH2 deformations at 2925, 1368 and 780 cm−1,
a peak of Si–O–Si stretching mode due to Piranha treat-
ment for SiH and thermal oxidation for SiO2 at 1090-1010
cm−1. In the case of the SiH sample, the characteristic peak
of backbone Si–H bonds at 2100 cm−1 was also observed.
FTIR characterization cannot show structural differences
between APTES and APDMES: the two compounds have
the same alkyl chain but while APTES has three ethoxy
groups, that cause polymerization of compound and thus
a better coverage of surface, APDMES instead has two
Fig. 2 FTIR spectra of pSi powders (BS419) before and after the hydrosilylation (a) and after annealing and hydrosilylation (b)
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Fig. 3 FTIR spectra of porous silicon BS419 (a) and oxidized porous silicon BS445 (b) powders before and after the silanization with APTES
and APDMES
methyl groups and one ethoxy group and does not poly-
merize. The DLS measurements confirmed the correct func-
tionalization of particles surface due to a change of sample
zeta potential from -16 (± 4) mV to +7 (± 3) mV after
silanization.
2.2.2 HPLC Based Chemical Reactivity Assay
When incubated with 20 mg of as-etched pSi, the
Lansoprazole-methanol solution showed a maximum degra-
dation of 30% compared with a 20 mg sample of commer-
cially available porous silica (Davisil, 60A˚) where degra-
dation is less than 0.02% (Fig. 4). Previous results have
shown that when the Lansoprazole-methanol solution was
incubated with samples of thermally passivated pSi, the pro-
portion of Lansoprazole degradation was seen to decrease
as the temperature used to passivate the silicon skeleton was
increased over the range 500-800 ◦C [49].
Table 3 FTIR peak values of porous silicon/silica powders after
silanization
The Lansoprazole mediated degradation of oxide-
passivated and derivatized samples is shown in Table 4.
Biosilicon material (BS445) that was passivated at 400 ◦C
and annealed in the presence of nitrogen was found to be
highly reactive. This batch showed almost complete degra-
dation (95%) of Lansoprazole; more than 65% than the
as-anodized control batch which degrades Lansoprazole by
28-30%. The hydrosilylation of anodised batches reduced
degradation significantly to 12.32% whereas hydrosilyla-
tion and annealing further reduced it to 3.95%. Derivatiza-
tion of anodised batch with APDMES resulted in a slight
decrease in degradation, while with APTES the reactiv-
ity was seen to lower significantly (0.58%). pSi samples
(BS419) which have been oxide-passivated at 700 ◦C for
more than 16 hours and then derivatized showed low reac-
tivity values of <1%.
Table 4 shows HPLC measurement of surface reactivity
of porous silicon powders (BS419 & BS445) after varied
treatments.
2.3 Dye Based Reactivity Assay
A fluorimetric dye method was used for measuring the
reactivity of porous silicon samples. Chemical reactivity of
porous silicon has been ascribed to hydrides associated with
the surfaces of the particles (12,21). These hydride surfaces
reduce Resazurin (blue), a marginally fluorescent dye, to
pink Resorufin which is highly fluorescent.
A linear relationship between Resorufin concentration
and fluorescence was seen over the concentration range
from 0.07-1.68 μg/mL with an R2 value of 0.9965 (Fig. 5).
This standard plot was used to quantify the amount of
Resazurin converted to Resorufin due to the presence of
hydride bonds at the surface. The method was validated
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Fig. 4 Chromatograms of (a)
free Lansoprazole and
Lansoprazole following
incubation with (b) commercial
sol-gel SiO2 (c) unpassivated
porous silicon
for accuracy, linearity and specificity. Potential interference
from the derivatization reagents (APTES, APDMES and
decene) on the fluorescence assay was found to be negligi-
ble or within the acceptable limits of a fluorimetric assay for
all three reagents (Table 5).
The amount of Resorufin produced can be used as a
direct measurement of the chemical reactivity of the sam-
ple. As-anodized or native oxide passivated pSi samples
cannot be analysed by this assay due to poor wettabil-
ity; therefore slightly passivated controls (500 ◦C for 1
hour) are used as a positive control in this assay. When
20 mg of this form of pSi was incubated with 1ml of
(2.5 μg/ml) Resazurin, approximately 2.2-2.4 μg/mL of
Resorufin was measured. Incubation with porous silica on
other hand generates only 0.01 μg/mL of Resorufin under
similar conditions. The dye based data on reactivity of pSi
samples are shown in Table 5. With hydrosilylated pSi sam-
ples (as with HPLC) it was noted that APDMES derivatized
samples showed higher reactivity compared with deriva-
tization by APTES. While hydrosilylation alone did not
reduce the reactivity significantly, annealing and hydrosi-
lylation proved to reduce the hydride content more effec-
tively. Oxidized batches showed significantly lower reactiv-
ity after hydrosilylation with APDMES and the improve-
ment is even more pronounced after hydrosilylation with
APTES.
Table 4 HPLC measurement
of surface reactivity of porous
silicon powders (BS419 &





BS445 Si-H annealed (400◦C in nitrogen) 94.9
BS445 Si-H & APDMES 16.51
BS445 Si-H & hydrosilylation 12.32
BS445 Si H-annealed & hydrosilylation 3.95
BS419 Si-H & oxidation & APDMES 0.64
BS445 Si-H & APTES 0.58
BS419 Si-H & oxidation 0.54
BS419 Si-H & oxidation & APTES 0.30
Sol gel silica (control) 0.01
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Fig. 5 Relationship of Fluorescence (y-axis) to Resorufin Concentra-
tion (x-axis)
2.3.1 Chemography Results
As-etched pSi can generate darkening on a photographic
plate within 10 minutes exposure (28). When as-etched pSi
and 800 ◦C passivated (rotary furnace, 16 hours) pSi were
exposed for 4 hours at 100% humidity, only as-etched pSi
showed a dark spot while the oxidized sample showed no
image, indicating that the rate of silane emission from this
sample is much slower or negligible (Fig 6). While hydrosi-
lylated samples showed a strong image after 20 hours, pSi
treated with APTES and APDMES showed a faint image
after 20 hours which was stronger after 72 to 100 hours.
Samples which were passivated for 700 ◦C for 16 hours
showed a faint image after 100 hours, which was com-
pletely absent after additional hydrosilylation with APTES
or APDMES.
Figure 6 provides an example of the chemographic
effects seen and summarized in Table 6. Figure 6a shows
the image of powders before exposing them to photographic
film and Fig. 6b shows a strong image seen from the Si-
H hydrosilylated sample; a faint image seen from the Si-H
APDMES sample; and no image seen from Si-H & APTES
and Si-H annealed samples.
Table 5 Dye reactivity of porous silicon powders (BS419 & BS445)
after varied treatments
Chemical passivation treatments Dye reactivity/Resorufin
Concentration (μg/mL)
Si-H & APDMES 1.28
Si-H & hydrosilylation 1.13
Si-H & oxidation 1.00
Si-H & APTES 0.79
Si H-annealed & hydrosilylation 0.68
Si-H & oxidation & APDMES 0.18
Si-H & oxidation & APTES 0.02
Sol gel silica (control) 0.02
a 
b 
Fig. 6 a photograph b chemograph of four samples after 20 hour
exposure. (From left to right: Si-H hydrosilylated; Si-H annealed in
nitrogen; Si-H APDMES; Si-H APTES)
3 Discussion
Residual chemical reactivity of oxidized porous silicon,
as quantified by these specific assays and compared with
amorphous silica, could in principle arise from a number
of sources that we now discuss in turn. Topics addressed
are silicon-hydride bond removal and its re-formation, trace
silane emission, trace etch residues, trace solvents, trace
metal contamination and the pH microclimate within the
pores.
Residual silicon-hydride bonding arrangements are the
primary candidate for residual chemical reactivity. Stoichio-
metric amorphous silica can be rendered more reactive by
the introduction of such hydride bonding [31, 32]. Deriva-
tization of porous silicon, by introduction of silicon-carbon
bonding, does not remove all such hydride [12, 33], even
when side-reactions are minimized [34]. This is generally
ascribed to steric hindrance effects [12] but could also be
due to some silicon-hydride bonding being within the sil-
icon skeleton, as recently proposed [35]. In this regard,
thermal dehydrogenation should be much more effective
at removing all silicon-hydride, both surface and internal
species. Due to its thermal stability, surface monohydride
is reported to require temperatures above 550 ◦C for its
removal. [36] Hydrogen trapped internally by point defects
within the skeleton could need temperatures as high as 700
◦C [37]. For this reason, samples were oxidized at 700 ◦C
for a long duration and, at least by FTIR, silicon-hydride
was reduced to undetectable levels (see Fig. 3b). However,
even if silicon-hydride is completely thermally removed,
the interaction of residual elemental silicon in the porous
Silicon
Table 6 Chemography of
porous silicon powders (BS419
& BS445) after varied
treatments
Chemical passivation treatments Chemography results
Si-H & hydrosilylation strong image after 20 hours
Si-H & APTES faint image after 20 hours; strong image after 72 hours
Si H & APDMES faint image after 20 hours; stronger image after 100 hrs
Si H- annealed & hydrosilylation very faint image after 100 hours exposure
Si H , oxidation and APDMES no image after100 hours exposure
Si H, oxidation and APTES no image after100 hours exposure
Sol gel silica (control) no image after 100 hours exposure
structure with aqueous environments can lead to its reintro-
duction. Convincing evidence for silicon-hydride creation
from silicon surfaces during alkali etching [38], tribochem-
ical etching in water [39, 40] and storage in weakly alkali
solutions like body fluids [41] is available in the literature.
Gaseous silane emission is a second potential source of
reactivity [7], especially for biological molecules stored for
long periods within the mesoporous structure. Evidence for
trace silane emission from both silicon and porous silicon
comes from chemography studies [20, 42], FTIR [42, 43]
and mass spectrometry [44]. Silane, like surface silicon-
hydride bonding, is a potential reducing agent that could
react with the two molecular probes used in these assays.
Tests where the dye solution was indirectly exposed to
silane gas emission from unpassivated porous silicon how-
ever were inconclusive, possibly due to its rapid hydrolysis
by water during transit [Shabir Q, Loni A. unpublished
data]. For the removal of silicon trihydride groups thought
to generate monosilane, thermal treatments should be very
effective; this is in accord with the nitrogen annealing treat-
ments having a pronounced effect with regard to silane
emission (no chemographic image in Fig. 6) but residual
monohydride content (residual activity) in both drug assay
(Table 4) and dye assay (Table 5).
Trace etch residues, such as silicon tetrafluoride and
hexafluorosilicic acid, could potentially introduce chem-
ical reactivity [22]; however, rigorous water and solvent
rinsing with multiple exchanges was employed in sample
preparation. Fluoride levels in selected batches were unde-
tectable by XRF and XPS [Loni A. unpublished data 45]
but the sensitivity of these techniques for this element is not
particularly high. Trace solvent levels in selected batches
were also quantified and showed ethanol/methanol content
at pharmacopeia-acceptable ppm levels (see Table 1).
The primary trace metal contaminants detected were zir-
conium ∼1000 ppm (from the zirconia ball milling process),
copper (17-22 ppm) and nickel (11-12 ppm). Arsenic, cad-
mium, mercury, lead, aluminum, barium, chromium, tung-
sten, molybdenum, platinum and manganese were all below
the detection limit of XRF (Table 1). The presence of zir-
conium has potential relevance to the final topic discussed
next; the surface acidity of oxidized porous silicon.
The pH assays demonstrated that oxidized porous silicon
microparticles had lower pH values than commercial silicas
prepared by sol-gel technology (e.g. pH 5-7) but comparable
values to pharmacopeia-grade fumed silicas like Cab-O-Sil
(pH 3.6-4.5). The monomer degradation product, orthosili-
cic acid, is weakly acidic with a pKa of 9.9 [45]. Polysilicic
acids that can arise from hydrolysis-induced supersatura-
tion are stronger acids than the monomer, with pKa values
up to 6.5 [45]. One minor contaminant detected in oxidized
porous silicon that could influence microclimate pH is zirco-
nium from the ball milling process. Although zirconia is an
established biomaterial [46], the incorporation of zirconium
into silica is known to increase catalytic activity via Lewis
site acidity [47]. Subsequent preliminary tests have shown
the drug-based HPLC assay to be strongly pH sensitive, but
the dye-based fluorometric assay less so [Webb K, Shabir
Q. unpublished data]. Nevertheless all three assays appear
to have value in optimizing porous silicon passivation for
extended dry and wet storage API stability testing.
Biodegradable porous silicon is currently under assess-
ment as a biomaterial for a wide range of therapeutic
medical applications, including brachytherapy, chemother-
apy, theranostics and tissue engineering [48]. Its in-vivo
biocompatibility is the subject of an increasing number of
studies [49] but in-vitro pharmacopeia-grade testing is also
essential for translation of those applications requiring drug
delivery into clinical evaluation. We have provided some
assays and discussed some issues that should be helpful in
this regard.
4 Conclusions
When minimizing the chemical reactivity of porous sili-
con for drug delivery applications, attention needs to be
given to complete removal of silicon hydride bonding, effec-
tive rinsing and drying techniques that remove electrolyte
components and etch residues, trace metal contamination
arising from microparticle batch manufacture and the pH
microclimate within the pores. Drug and dye-based storage
assays have been developed to quantify residual reactiv-
ity. Chemography is currently only a qualitative assay,
Silicon
but results appear to broadly correlate with the molecular
assays. Further research continues to elucidate the causes
of residual chemical reactivity, as monitored by these sensi-
tive assays, and the extent to which the data correlates with
model API stability during lengthy storage.
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